Equine infectious anemia virus blocks interferon responses through Rev-mediated activation of the stress granule-PKR-eIF2α pathway
PLOS Pathogens · 21.05.2026 · 22 (5) · e1014262
DOI: 10.1371/journal.ppat.1014262 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 21.05.2026. Verfasst von Huiling Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin…. Hauptthemen laut MEDLINE: eIF-2 Kinase, Infectious Anemia Virus, Equine, Eukaryotic Initiation Factor-2, Stress Granules. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, National Natural Science Foundation of China, Youth Innovation Program of the Chinese Academy of Agricultural Sciences.
Abstract (Originalsprache)
Type I interferons (IFNs) play a pivotal role in antiviral defence by inducing interferon-stimulated genes (ISGs) that target multiple stages of viral replication. Equine infectious anemia virus (EIAV) is an ancient lentivirus that establishes long-term asymptomatic infections in equids, suggesting its exceptional immune evasion capabilities. However, the mechanisms by which EIAV modulates IFN responses remain unclear. Here, we demonstrate that EIAV infection attenuates ISG expression at the post-transcriptional level. The viral Rev protein plays a central role by interacting with the stress granule (SG) nucleating protein Ras-GTPase-activating protein binding protein 1 (G3BP1) to induce SG formation. This triggers the phosphorylation of double-stranded RNA-dependent protein kinase (PKR) and eukaryotic initiation factor 2α (eIF2α), which then block the translation of ISGs. Knockdown of G3BP1 or inhibition of PKR activation restores ISGs expression and enhances the antiviral effect of IFN against EIAV. Furthermore, the dimerization and RNA-binding domains of Rev are essential for SG assembly and the subsequent inhibition of IFN responses. Collectively, our findings reveal that EIAV has evolved a unique strategy to evade IFN responses, where the Rev protein reprograms SGs into proviral platforms by suppressing the translation of ISGs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang, China.
- China-Kazakhstan Joint Laboratory for Herbivorous Animal Disease Research, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang, China.
- Institute of Western Agriculture, Chinese Academy of Agricultural Sciences, Changji, China.
ORCID-Profile: Xiaojun Wang
Förderung
- Natural Science Foundation of Heilongjiang Province
- National Natural Science Foundation of China
- Youth Innovation Program of the Chinese Academy of Agricultural Sciences
- China Postdoctoral Science Foundation
Zitieren
APA
Ren, H., Chen, K., Zhou, B., Zhang, W., Wang, X. F., & Wang, X. (2026). Equine infectious anemia virus blocks interferon responses through Rev-mediated activation of the stress granule-PKR-eIF2α pathway. PLOS Pathogens, 22(5), e1014262. https://doi.org/10.1371/journal.ppat.1014262
Vancouver
Ren H, Chen K, Zhou B, Zhang W, Wang XF, Wang X. Equine infectious anemia virus blocks interferon responses through Rev-mediated activation of the stress granule-PKR-eIF2α pathway. PLOS Pathogens. 2026;22(5):e1014262. doi:10.1371/journal.ppat.1014262
BibTeX
@article{Ren2026,
author = {Ren, Huiling and Chen, Kewei and Zhou, Bingqian and Zhang, Weiguo and Wang, Xue-Feng and Wang, Xiaojun},
title = {Equine infectious anemia virus blocks interferon responses through Rev-mediated activation of the stress granule-PKR-eIF2α pathway},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {5},
pages = {e1014262},
doi = {10.1371/journal.ppat.1014262}
}
EUVIMED